CN101608170B - Hydrogen-producing engineering bacteria and application thereof - Google Patents
Hydrogen-producing engineering bacteria and application thereof Download PDFInfo
- Publication number
- CN101608170B CN101608170B CN2008101152311A CN200810115231A CN101608170B CN 101608170 B CN101608170 B CN 101608170B CN 2008101152311 A CN2008101152311 A CN 2008101152311A CN 200810115231 A CN200810115231 A CN 200810115231A CN 101608170 B CN101608170 B CN 101608170B
- Authority
- CN
- China
- Prior art keywords
- sequence
- dna fragmentation
- hydrogen
- hybo
- homology arm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000001257 hydrogen Substances 0.000 title claims abstract description 123
- 229910052739 hydrogen Inorganic materials 0.000 title claims abstract description 123
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title claims abstract description 110
- 241000894006 Bacteria Species 0.000 title claims abstract description 83
- 241000588915 Klebsiella aerogenes Species 0.000 claims abstract description 67
- 101150099257 hybO gene Proteins 0.000 claims abstract description 32
- 101150108643 hycA gene Proteins 0.000 claims abstract description 17
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 8
- 238000013467 fragmentation Methods 0.000 claims description 49
- 238000006062 fragmentation reaction Methods 0.000 claims description 49
- 239000002773 nucleotide Substances 0.000 claims description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 25
- 230000009849 deactivation Effects 0.000 claims description 22
- 230000006801 homologous recombination Effects 0.000 claims description 16
- 238000002744 homologous recombination Methods 0.000 claims description 16
- 239000012634 fragment Substances 0.000 claims description 14
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 229930101283 tetracycline Natural products 0.000 claims description 7
- 238000011144 upstream manufacturing Methods 0.000 claims description 7
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 229940088710 antibiotic agent Drugs 0.000 claims description 6
- 230000008521 reorganization Effects 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 2
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 claims description 2
- 238000003259 recombinant expression Methods 0.000 claims description 2
- 230000009261 transgenic effect Effects 0.000 claims description 2
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 abstract description 38
- 239000000758 substrate Substances 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 7
- 230000007613 environmental effect Effects 0.000 abstract description 3
- 230000000415 inactivating effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 description 22
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 19
- 102000004190 Enzymes Human genes 0.000 description 19
- 230000008569 process Effects 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 238000012216 screening Methods 0.000 description 12
- 230000008685 targeting Effects 0.000 description 12
- 239000013598 vector Substances 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 235000019253 formic acid Nutrition 0.000 description 10
- 230000012010 growth Effects 0.000 description 10
- 150000002431 hydrogen Chemical class 0.000 description 10
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 108010020056 Hydrogenase Proteins 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 230000005611 electricity Effects 0.000 description 7
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000004907 flux Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000012807 shake-flask culturing Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000193403 Clostridium Species 0.000 description 4
- 241000605909 Fusobacterium Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000008121 dextrose Substances 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000008676 import Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 4
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 4
- 229940049547 paraxin Drugs 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- 108010078791 Carrier Proteins Proteins 0.000 description 3
- 241001112695 Clostridiales Species 0.000 description 3
- 241000588914 Enterobacter Species 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 230000000243 photosynthetic effect Effects 0.000 description 3
- 238000012797 qualification Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 108700005075 Regulator Genes Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 2
- 102220369445 c.668T>C Human genes 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 108010072136 iron hydrogenase Proteins 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102220004457 rs11567847 Human genes 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000012882 sequential analysis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241001494908 Akihito Species 0.000 description 1
- 101000755953 Bacillus subtilis (strain 168) Ribosome maturation factor RimP Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000703924 Enterobacter cloacae IIT-BT 08 Species 0.000 description 1
- 108010074122 Ferredoxins Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 229910003271 Ni-Fe Inorganic materials 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 102220369446 c.1274G>A Human genes 0.000 description 1
- 102220369447 c.1352G>A Human genes 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000007260 kalia Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229930010796 primary metabolite Natural products 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 102220023256 rs387907547 Human genes 0.000 description 1
- 102220277134 rs776745497 Human genes 0.000 description 1
- 238000012772 sequence design Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000009871 tenuigenin Substances 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses hydrogen-producing engineering bacteria and application thereof. The hydrogen-producing engineering bacteria are a) engineering bacteria obtained by inactivating delta hybO protein in E.aerogenes IAM1183 or b) engineering bacteria obtained by inactivating delta hybO protein and delta hycA protein in E.aerogenes IAM1183, wherein the amino acid sequence of the delta hybO protein is sequence 1 in a sequence list; and the amino acid sequence of the delta hycA protein is sequence 4 in the sequence list. The hydrogen-producing engineering bacteria can be applied to biological hydrogen production and are of great directive significance to biological hydrogen production. Moreover, the hydrogen-producing engineering bacteria have the advantages of strong environmental adaptability, wide substrate utilization range, strong substrate utilization capability and high hydrogen-producing efficiency.
Description
Technical field
The present invention relates to hydrogen-producing engineering bacteria and application thereof.
Background technology
Nowadays the fossil energy system of having set up since the world industry revolution of 18th century is being faced with two challenges greatly: 1) the fossil energy reserves reduce day by day, are faced with exhausted danger; 2) burning of fossil oil has produced a large amount of pollution substances, particularly CO
2The Greenhouse effect that the isothermal chamber gas purging causes, the environment of depending on for existence to the mankind brings huge threat.Therefore, the renewable and clean energy resource of Sustainable Development, progressively substituting fossil energy is the grand strategy problem that concerns national energy security, environmental safety and social stability peaceful development.
Hydrogen Energy is as substituting one of clean energy the future that has potentiality, is energy carrier efficiently, has energy density height, cleaning, renewable, products of combustion and be water and characteristics such as pollution-free, is very good renewable energy source.At present, hydrogen mainly transforms (account for hydrogen source 96%) and water electrolysis hydrogen production (accounting for 4%) from the reformation of fossil oil, fails to break away from the dependence to original fossil energy.Therefore, how to utilize renewable resources to obtain the concern widely that hydrogen is subjected to people constantly.Biological hydrogen production is one of important channel that addresses this problem.Biological hydrogen production have normal temperature and pressure reaction, mild condition, environmentally friendly, can utilize discarded biological substance to be advantages such as substrate, can be with environmental pollution improvement, reduce disposal of pollutants and interrelate, be very good hydrogen production process.
The research of modern biological hydrogen production starts from the energy dilemma of the seventies in 20th century, and since the nineties, along with the further understanding of people to Greenhouse effect, biological hydrogen production has caused people's extensive attention more as the hydrogen production process of Sustainable development.Bio-hydrogen production technology comprises optical drive process and two kinds of routes of anaerobically fermenting.The former utilizes photosynthetic bacterium or algae directly conversion of solar energy to be hydrogen, is a very ideal process, but because the light utilising efficiency is very low, factors such as photoreactor difficult design are difficult to push to use at no distant date.What the latter adopted is the hydrogenogens anaerobically fermenting, and its advantage is that product hydrogen speed is fast, reactor design simple and can combines with discarded biological utilization, with respect to the former the easier industrial application that realizes in the near future.
Fermentation method hydrogen manufacturing starts from middle nineteen sixties, and the nineties comes into one's own, but progress and little.Late nineteen nineties is to the beginning of this century, and people recognize that ferment for hydrogen production is easier and realize industrialization in the near future, have increased the scientific research input of dark ferment for hydrogen production aspect greatly, have produced the basic research result of a collection of relevant culture process.The research of the hydrogen production process that combines with the abandoned biomass processing in recent years greatly increases, some of them have reached the pilot scale level, but mainly concentrate on reactor type design, the technical study, and the mixed culture hydrogen generation efficiency is lower than pure culture, total transformation efficiency is not high, and this is the bottleneck place of ferment for hydrogen production just also.Solving the key of ferment for hydrogen production bottleneck, is to realize technological breakthrough, improves the hydrogen yield.Studies show that, only, can't fundamentally break through the low problem of hydrogen generation efficiency, must pay attention to the research and development of highly effective hydrogen yield bacterial classification from the angle of technology.
For many years, the hydrogenogens kind of using in the dark ferment for hydrogen production mainly comprises enterobacter (Enterobacter), fusobacterium (Clostridium), Escherichia (Escherichia) and bacillus (Bacillus), and is wherein maximum with the correlative study of enterobacter and fusobacterium especially.Fusobacterium produces the hydrogen rate and can reach 2.36mol/mol glucose, enteroaerogen belongs to product hydrogen rate and reaches as high as 3mol/mol glucose (being 6mol/mol sucrose) [Kumar, N.and Das, D.Bioprocess Engineering 23,205-208 (2000)], [Kumar, N.andDas, D.Process Biochemistry 35,589-593 (2000)].With clostridium (Clostridium sp) is that the mechanism of the obligatory anaerobic bacteria fermentation and hydrogen production of representative is: generate pyruvic acid after the glucose glycolysis, in forming the acetic acid process, a part of electronics forms hydrogen by ferredoxin under the effect of hydrogen enzyme.One mole glucose can form 4 mol of hydrogen and 2 molecule acetic acid.Therefore, in the time of the obligatory anaerobic bacteria fermentation and hydrogen production, must follow organic acid formation such as acetic acid.Amphimicrobian hydrogenogens E.aerogenes separates approach by sugar and tricarboxylic acid cycle (TCA) approach produces NADH and ATP, the hydrogen enzyme is converted to hydrogen by NADH with proton, producing hydrogen theoretical transformation rate is that 1 mole of glucose forms 12mol hydrogen, is far longer than the hydrogen yield of obligatory anaerobic bacteria.Therefore, E.aerogenes is the important bacterial classification of the efficient ferment for hydrogen production technology of exploitation.
Along with the develop rapidly of biotechnology, the simple bacterial screening and the optimization of culture process can not have been satisfied the demand that improves hydrogen generation efficiency.The research of ferment for hydrogen production need enter cell interior, by the transformation of hydrogen enzyme and metabolism network thereof being strengthened the hydrogen process of producing.On gene pool, can obtain at present to surpass 100 kinds hydrogenase gene sequence [Paulette M.Vignais, Bernard Billoud, Jacques Meyer.FEMS MicrobiologyReviews 25,455-501 (2001)], but still have the hydrogenase gene of a large amount of known hydrogenogens strains not cloned as yet, seeking more hydrogenase gene is the important directions [Kalia of biological hydrogen production research, V.C., Lal, S., Ghai, R., Mandal, M.and Chauhan, A.Trends in Biotechnology 21,152-156 (2003)].Different hydrogen enzymes have different functions, compare with other enzyme system, and people are also very limited to the understanding of hydrogen enzyme.
At present, the more clearly of research is the gene of colibacillary hydrogen enzyme I, II, III and IV, and they all belong to Ni-Fe hydrogen enzyme, relevant with product hydrogen [Andrews, S.C., Berks of hydrogen enzyme III wherein with IV, B.C., Mcclay, J., Ambler, A., Quail, M.A., Golby, P.and Guest, J.R.Microbiology143,3633-3647 (1997)], and I, II are relevant with suction hydrogen process.The hydrogen enzyme of fusobacterium all belongs to iron hydrogen enzyme, and three clostridial iron hydrogen enzymes have sequencing result, but not clear about its subsidiary gene, regulatory mechanism.Be cloned into clostridial iron hydrogenase gene, and in photosynthetic bacterium, obtained heterogenous expression, strengthened the product hydrogen process of photosynthetic bacteria.The expression of clostridial iron hydrogenase gene in intestinal bacteria be not success but, may be since clostridium and intestinal bacteria for [the Yasuo Asada that causes inequality of the subsidiary gene system of iron hydrogen expression of enzymes, Yoji Koike, JorgSchnackenberg, Masato Miyake, Ieaki Uemura, Jun Miyake.Biochimica etBiophysica Acta 1490,269-278 (2000)].Recently, the method by iron hydrogen enzyme conserved sequence design such as Mishra J. clones the iron hydrogen enzyme about 450bp from E.cloacae IIT-BT08, and in the intestinal bacteria that do not produce hydrogen heterogenous expression, verified its function, the result shows that this hydrogen enzyme is positioned at tenuigenin [Mishra, J., Kumar, N., Ghosh, A.K.and Das, D.International Journal of Hydrogen Energy27,1475-1479 (2002)], [Mishra, J., Khurana, S., Kumar, N., Ghosh, A.K.andDas, D.Biochemical and Biophysical Research Communications 324,679-685 (2004)].The early-stage Study of enteroaerogen E.aerogenes shows, on its cytolemma, the NADH effect that produces in hydrogen enzyme and the cell generates hydrogen [Nakashimada, Y., Rachman, M.A., Kakizono, T.andNishio, N.International Journal of Hydrogen Energy 27,1399-1405 (2002)].Therefore study hydrogen enzyme characteristic, gene and the biological function explore thereof of this Pseudomonas, significant for the technological breakthrough that realizes raising enteroaerogen product hydrogen yield.
Studies show that to what intestinal bacteria produced the hydrogen process intestinal bacteria can directly utilize formic acid, also the formic acid that can produce in assimilation glucide metabolic process is substrate, and under the effect of formic acid lyase system, decompose formic acid generates CO
2And H
2[Akihito?Yoshida,Taku?Nishimura,Hideo?Kawaguchi,1?Masayuki?Inui,andHideaki?Yukawa*.Appl?Environ?Microbiol.71:6762-6768(2005)]。It is to produce the fastest approach of hydrogen that formic acid produces the hydrogen approach.
Enteroaerogen is a facultative anaerobe, and fast growth under anaerobic can produce hydrogen, and advantage such as it is wide to have the substrate of utilization scope, and growth adaptability is strong, is the bacterial strain with good industrial proterties.Existing many reports about enteroaerogen product hydrogen, but be mostly aspect technology and cultivation [E.Palazzi, B.Fabiano, P.Perego.Bioprocess Eng.22:205-213 (2000) .], the relevant relevant gene of hydrogen that produces is also without any report.Studies show that, enteroaerogen has the utilize formic acid similar with intestinal bacteria and produces the ability [Tatsuo of hydrogen, K., Shigeharu, T.Mar Biotechnol.7:112-118 (2005) .], and it has the hydrogen of suction process, [the Y.L Ren. that exists that inhales the hydrogen enzyme is promptly arranged, X.H.Xing., C.Zhang., and Z.X.Gou.Biotechnol Lett.27 (14): 1029-1033 (2005) .].Therefore clone enteroaerogen and utilize formate transporters to produce the gene and the suction hydrogenase gene of hydrogen, utilize formic acid to produce the process of hydrogen and consumption hydrogen to understanding it, thereby utilize the formate transporters biological hydrogen production to have great importance.Clone's formic acid hydrogenase gene and suction hydrogenase gene also are to useful the replenishing of hydrogenase gene family.
Summary of the invention
The purpose of this invention is to provide hydrogen-producing engineering bacteria and application thereof.
Hydrogen-producing engineering bacteria provided by the invention, be following a) or b) engineering bacteria:
A) engineering bacteria that obtains of the Δ hybO albumen among the deactivation E.aerogenes IAM1183;
B) engineering bacteria that obtains of Δ hybO albumen among the deactivation E.aerogenes IAM1183 and Δ hycA albumen;
The proteic aminoacid sequence of described Δ hybO is the sequence 1 in the sequence table; The proteic aminoacid sequence of described Δ hycA is the sequence 4 in the sequence table.
Δ hybO albumen among the described deactivation E.aerogenes IAM1183 can be realized by dna fragmentation Q is imported among the described E.aerogenes IAM1183; Described dna fragmentation Q is followed successively by homology arm T to the downstream from the upstream
1, dna fragmentation N, homology arm T
2Described homology arm T
1With homology arm T
2Can with the proteic encoding gene generation of described Δ hybO homologous recombination, the described Δ hybO of deactivation albumen; Described dna fragmentation N is the antibiotics resistance fragment.
The nucleotide sequence of the proteic encoding gene of described Δ hybO is the sequence 2 in the sequence table; Described homology arm T
1Nucleotide sequence be sequence 7 in the sequence table; Described homology arm T
2Nucleotide sequence be sequence 8 in the sequence table; Described dna fragmentation N is the tetracyclin resistance fragment.
The nucleotide sequence of described dna fragmentation Q specifically can be the sequence 3 in the sequence table.
Δ hybO albumen among the described deactivation E.aerogenes IAM1183 and Δ hycA albumen can be realized by dna fragmentation P and dna fragmentation Q are imported among the described E.aerogenes IAM1183; In the actually operating, the importing of dna fragmentation P and dna fragmentation Q can be taked order arbitrarily successively, and as importing dna fragmentation P earlier, screening obtains recombinating and imports dna fragmentation Q again in the reorganization bacterium behind the bacterium;
Described dna fragmentation P is followed successively by homology arm T to the downstream from the upstream
3, dna fragmentation M, homology arm T
4Described homology arm T
3With homology arm T
4Can with the proteic encoding gene generation of described Δ hycA homologous recombination, the described Δ hycA of deactivation albumen; Described dna fragmentation M is the antibiotics resistance fragment;
Described dna fragmentation Q is followed successively by homology arm T to the downstream from the upstream
1, dna fragmentation N, homology arm T
2Described homology arm T
1With homology arm T
2Can with the proteic encoding gene generation of described Δ hybO homologous recombination, the described Δ hybO of deactivation albumen; Described dna fragmentation N is the antibiotics resistance fragment.
The nucleotide sequence of the proteic encoding gene of described Δ hybO is the sequence 2 in the sequence table; Described homology arm T
1Nucleotide sequence be sequence 7 in the sequence table; Described homology arm T
2Nucleotide sequence be sequence 8 in the sequence table; Described dna fragmentation N is the tetracyclin resistance fragment; The nucleotide sequence of the proteic encoding gene of described Δ hycA is the sequence 5 in the sequence table; Described homology arm T
3Nucleotide sequence be sequence 9 in the sequence table; Described homology arm T
4Nucleotide sequence be sequence 10 in the sequence table; Described dna fragmentation M is the kalamycin resistance fragment.
The nucleotide sequence of described dna fragmentation Q specifically can be the sequence 3 in the sequence table; The nucleotide sequence of described dna fragmentation P specifically can be the sequence 6 in the sequence table.
The present invention also protects a kind of dna fragmentation Q, and dna fragmentation Q is followed successively by homology arm T to the downstream from the upstream
1, dna fragmentation N, homology arm T
2Described homology arm T
1With homology arm T
2Can with the proteic encoding gene generation of the Δ hybO homologous recombination of E.aerogenes IAM1183, deactivation Δ hybO albumen; The proteic aminoacid sequence of described Δ hybO is the sequence 1 in the sequence table; Described dna fragmentation N is the antibiotics resistance fragment.
The nucleotide sequence of the proteic encoding gene of described Δ hybO is the sequence 2 in the sequence table; Described homology arm T
1Nucleotide sequence be sequence 7 in the sequence table; Described homology arm T
2Nucleotide sequence be sequence 8 in the sequence table; Described dna fragmentation N is the tetracyclin resistance fragment.
The nucleotide sequence of described dna fragmentation Q most preferably is the sequence 3 in the sequence table.
Contain the expression cassette of described dna fragmentation Q or recombinant expression vector or transgenic cell line or the reorganization bacterium all belongs to protection scope of the present invention.
The present invention is a starting strain with enteroaerogen E.aerogenes, by the hydrogen production associated protein encoding gene among the enteroaerogen E.aerogenes is carried out deactivation, obtained the bacterial strain that two strain formate transporters hydrogen production potentials improve, can be applicable to biological hydrogen production, biological hydrogen production is had huge directive significance.
The engineering bacteria that the present invention obtains has the following advantages:
1) starting strain E.aerogenes IAM1183 is a facultative anaerobe, all can grow fast under aerobic, anaerobic condition, and is strong to environmental compatibility; Utilize its carry out biological hydrogen production have the substrate of utilization scope wide, utilize the substrate ability strong and produce the hydrogen advantage of higher, be to have the potential strain excellent that is applied to industrialization hydrogen manufacturing.
2) the engineering bacteria E.aerogenes IAM1183-O and the engineering bacteria E.aerogenesIAM1183-AO of the present invention's acquisition, except having original bacterium 1) advantage, it is stronger also to have the substrate utilization ability, characteristics, especially E.aerogenes IAM1183-AO that hydrogen production potential further improves.
Following embodiment is convenient to understand better the present invention, but does not limit the present invention.
Description of drawings
Fig. 1 is monoclonal antibody and the two anti-screening figure of engineering bacteria E.aerogenes IAM1183-O
Fig. 2 is that the PCR of engineering bacteria E.aerogenes IAM1183-O identifies figure
Fig. 3 is monoclonal antibody and the two anti-screening figure of engineering bacteria E.aerogenes IAM1183-A
Fig. 4 is that the PCR of engineering bacteria E.aerogenes IAM1183-A identifies figure
Fig. 5 is that the PCR of engineering bacteria E.aerogenes IAM1183-AO identifies figure
The growth curve OD of Fig. 6 engineering bacteria
600
PH in Fig. 7 engineering bacteria process of growth changes
The H of Fig. 8 engineering bacteria
2Generate and analyze
The CO of Fig. 9 engineering bacteria
2Generate and analyze
Embodiment
Experimental technique among the following embodiment if no special instructions, is ordinary method.
Used primer is as follows in following examples:
hycA-Km-fw:
CTGCA?ATTCGCTGGT?TCAGGGCATC?ACCCTGTCAA?AAGCGATAGGCTCCGCCCCCCTGA;
hycA-Km-rv:
GGCTTAAATCCACCGGCTGGTCGTGTTCCATGGCGTCATACAGGTGGCAC?TTTTCGGGG;
HybO-tet-fw:
AATCTCTGCTTCGTGCAACGCATCCAACGGTAGAAAACCTTTTGGTGACTGCGCTCCTC;
HybO-tet-rv:
GATACCTTCT?TCGTTACAGC?CATAGCAAGG?GTGACCAATCTGTTGTTGCTCAGGTCGCA;
hycA-fw:CTGCAATTCGCTGGT?TCAGGGCATC;
hycA-rv:GGCTTAAATCCACCG?GCTGGTCGTG;
hybO-fw:AATCTCTGCT?TCGTGCAACGCATC;
hybO-rv:GATACCTTCT?TCGTTACAGCCATA。
Culture medium prescription and purposes related in following examples are as follows:
(1) LB substratum (L
-1): peptone 10g, yeast soak powder 5g, NaCl 10g, agar powder 15g (adding during solid medium); Be used for bacterial classification short term storage and activation culture.
(2) dextrose culture-medium (L
-1): glucose 15g, peptone 5g, K
2HPO
43H
2O 14g, KH
2PO
46g, (NH
4)
2SO
42g, MgSO
47H
2O 0.2g; Be used for ferment for hydrogen production.
The acquisition of embodiment 1, enteroaerogen E.aerogenes IAM1183-O
Starting strain enteroaerogen (E.aerogenes IAM1183) is available from using microbe institute of Tokyo Univ Japan (IAM) strain library.
(Genbank NO:EF601126) carries out sequential analysis to the enteroaerogen gene order among the NCBI, designs a pair of primer HybO-tet-fw and HybO-tet-rv, and sequence is as follows:
HybO-tet-fw:
5’-
AATCTCTGCTTCGTGCAACGCATCCAACGGTAGAAAACCTTTTGGTGACTGCGCTCCTC-3’;
HybO-tet-rv:
5’-
GATACCTTCTTCGTTACAGCCATAGCAAGGGTGACCAATCTGTTGTTGCTCAGGTCGCA-3’。
The sequence of the band line in the primer is the homologous sequence of Δ hybO gene in the enteroaerogen (E.aerogenes IAM1183).
The mode that transforms by electricity with the pYM-red plasmid (in plum, Zhou Jianguang, Chen Wei, Li Shanhu, Huang Cuifen, the foundation of a kind of transferable recombined engineering pYM-Red of system. biological chemistry and biophysics progress .2005,32 (4) .) enteroaerogen of shocking by electricity is (among the E.aerogenes IAM1183, carry out paraxin (24mg/mL) resistance screening, from positive strain, extract the pYM-red plasmid and identify, obtained to contain the enteroaerogen (E.aerogenes IAM1183) of pYM-red recombinant plasmid.
With pACYC184 plasmid (Chang, A.C., and S.N.Cohen.1978.Construction andcharacterization of amplifiable multicopy DNA cloning vehicles derived fromthe P15A cryptic miniplasmid.J.Bacteriol.134:1141-1156.) DNA is a template, carry out pcr amplification with primer HybO-tet-fw and HybO-tet-rv, acquisition contains the linear DNA of tetracycline marker, with this linear DNA as targeting vector.Mode by electricity transforms imports targeting vector the enteroaerogen (E.aerogenes IAM1183) that contains the pYM-red plasmid.
Bacterium after transforming is coated on the monoclonal antibody LB flat board of the tsiklomitsin (4ug/ml) that contains, cultivated 1 day for 30 ℃; Then the bacterium that grows is transferred and contain on the two anti-LB flat board of tsiklomitsin (4ug/ml) and paraxin (24ug/ml), cultivated 1 day for 30 ℃.Monoclonal antibody and two anti-results of screening are seen Fig. 1, and left side figure is the figure of monoclonal antibody screening among Fig. 1, and right figure is the figure of two anti-screenings.
The clone who grows on the several two anti-substratum of picking at random, extract genomic dna, method by PCR identify targeting vector whether with karyomit(e) on target site homologous recombination has taken place, the used a pair of primer of PCR reaction is hybO-fw and hybO-rv, and the sequence of hybO-fw and hybO-rv is as follows:
hybO-fw?5’-AATCTCTGCT?TCGTGCAACG?CATC-3’;
hybO-rv?5’-GATACCTTCT?TCGTTACAGC?CATA-3’。
The PCR qualification result is seen Fig. 2, among Fig. 2, and 1:DNA 2000marker; 2:E.aerogenes IAM1183-O.As seen from the figure, the amplified production of E.aerogenes IAM1183-O has obtained the 1800bp object tape, and is consistent with expected results.The result shows that among the clone of acquisition, homologous recombination has taken place the target site on targeting vector and the karyomit(e).Will the saltant called after E.aerogenes IAM1183-O of homologous recombination have taken place.
The acquisition of embodiment 2, enteroaerogen E.aerogenes IAM1183-A
Starting strain enteroaerogen (E.aerogenes IAM1183) is available from using microbe institute of Tokyo Univ Japan (IAM) strain library.
(Genbank NO:EF601125) carries out sequential analysis to the enteroaerogen gene order among the NCBI, designs a pair of primer hycA-Km-fw and hycA-Km-rv, and the sequence of hycA-Km-fw and hycA-Km-rv is as follows:
hycA-Km-fw:
5’-
CTGCAATTCGCTGGTTCAGGGCATCACCCTGTCAAAAGCGATAGGCTCCGCCCCCCTGA-3’;
hycA-Km-rv:
5’-
GGCTTAAATCCACCGGCTGGTCGTGTTCCATGGCGTCATACAGGTGGCACTTTTCGGGG-3’。
The sequence of the band line in the primer is the homology arm of enteroaerogen (E.aerogenes IAM1183) Δ hycA.
The mode that transforms by electricity with the pYM-red plasmid (in plum, Zhou Jianguang, Chen Wei, Li Shanhu, Huang Cuifen, the foundation of a kind of transferable recombined engineering pYM-Red of system. biological chemistry and biophysics progress .2005,32 (4) .) enteroaerogen of shocking by electricity is (among the E.aerogenes IAM1183, carry out paraxin (24mg/mL) resistance screening, from positive strain, extract the pYM-red plasmid and identify, obtained to contain the enteroaerogen (E.aerogenes IAM1183) of pYM-red recombinant plasmid.
With the pET28a plasmid DNA is template, carries out pcr amplification with primer hycA-Km-fw and hycA-Km-rv, obtains to contain the linear DNA of kantlex mark, with this linear DNA as targeting vector.Mode by electricity transforms imports targeting vector the enteroaerogen (E.aerogenes IAM1183) that contains the pYM-red recombinant plasmid.Bacterium after transforming is coated on the monoclonal antibody LB flat board that contains kantlex (50mg/mL), cultivated 1 day for 30 ℃; Then the bacterium that grows is transferred and contain on the two anti-LB flat board of kantlex (50mg/mL) and paraxin (30mg/mL), cultivated 1 day for 30 ℃.Monoclonal antibody and two anti-results of screening are seen Fig. 3, and left side figure is the figure of monoclonal antibody screening among Fig. 3, and right figure is the figure of two anti-screenings.
The clone who grows on the several two anti-substratum of picking at random, extract genomic dna, method by PCR identify targeting vector whether with karyomit(e) on target site homologous recombination has taken place, the used a pair of primer of PCR reaction is hycA-fw and hycA-rv, and the sequence of hycA-fw and hycA-rv is as follows:
hycA-fw:5’-CTGCAATTCGCTGGTTCAGGGCATC-3’;
hycA-rv:5’-GGCTTAAATCCACCGGCTGGTCGTG-3’。
The PCR qualification result is seen Fig. 4, among Fig. 4, and 1:E.aerogenes IAM1183-A; (2:E.aerogenesIAM1183 contrast); 3:DNA 2000marker.As seen from the figure, the amplified production of E.aerogenes IAM1183-A has obtained the 1700bp object tape; The amplified production of E.aerogenes IAM1183 has obtained the band of 550bp, and is consistent with expected results.The result shows that among the clone of acquisition, homologous recombination has taken place the target site on targeting vector and the karyomit(e).Will the saltant called after E.aerogenesIAM1183-A of homologous recombination have taken place.
The acquisition of embodiment 3, enteroaerogen E.aerogenes IAM1183-AO
With E.aerogenes IAM1183-O is starting strain, deactivation Δ hycA albumen (method is with embodiment 2); Or be starting strain with E.aerogenes IAM1183-A, deactivation Δ hycO albumen (method is with embodiment 1) all can obtain mutant strain E.aerogenes IAM1183-AO.Below be starting strain with E.aerogenes IAM1183-A, make up E.aerogenes IAM1183-AO.
With the pACYC184 plasmid DNA is template, carries out pcr amplification with primer HybO-tet-fw and HybO-tet-rv, obtains to contain the linear DNA of tetracycline marker, with this linear DNA as targeting vector.Mode by electricity transforms imports targeting vector the enteroaerogen E.aerogenes IAM1183-A that contains the pYM-red plasmid.Bacterium after transforming is coated on the two anti-LB flat board that contains kantlex (50mg/mL) and tsiklomitsin (4mg/mL), cultivated 1 day for 30 ℃.
The clone who grows on the several two anti-substratum of picking at random, extract genomic dna, method by PCR identify targeting vector whether with karyomit(e) on target site homologous recombination has taken place, the used a pair of primer of PCR reaction is hybO-fw and hybO-rv, and the sequence of hybO-fw and hybO-rv is as follows:
hybO-fw?5’-AATCTCTGCT?TCGTGCAACG?CATC-3’;
hybO-rv?5’-GATACCTTCT?TCGTTACAGC?CATA-3’。
The PCR qualification result is seen Fig. 5, among Fig. 5, and 1:DNA 2000 marker; 2:E.aerogenes IAM1183-AO.As seen from the figure, the amplified production of E.aerogenes IAM1183-AO has obtained the 1800bp object tape, and is consistent with expected results.The result shows that among the clone of acquisition, homologous recombination has taken place the target site on targeting vector and the karyomit(e).Will the saltant called after E.aerogenes IAM1183-AO of homologous recombination have taken place.
The product hydrogen performance of embodiment 4, engineering bacteria and physiological property are measured
In different 70mL serum bottles, adorn the 20mL dextrose culture-medium respectively, engineering bacteria E.aerogenes IAM1183-O after will activating respectively and engineering bacteria E.aerogenes IAM1183-AO carry out shake-flask culture, and the wild bacterium after will activating simultaneously carries out the similarity condition shake-flask culture, in contrast.The concrete operations step is as follows:
(1) seed culture: adopt the 15ml centrifuge tube, LB substratum liquid amount 5ml is from solid plate inoculation, 37 ℃ of culture temperature, airbath shaking speed 170rpm, incubated overnight.
(2) anaerobism shake-flask culture: adopt 70ml serum bottle anaerobism culturing bottle, dextrose culture-medium liquid amount 20ml (using the air in nitrogen replacement culturing bottle top and the substratum in advance); Plant the inoculum size 2.5% (v/v) of daughter bacteria, 37 ℃ of culture temperature, airbath, shaking speed 170rpm.Cultivated 24 hours.
Three repetitions are established in test, and all results are multiple mean value three times, represent with mean+SD.
Collect the gas that engineering bacteria and wild bacterium produce respectively, utilize syringe to measure the gas volume that generates; Utilize spectrophotometer (UV-1206, SHIMADZU company (Japan)) to measure the growing state of thalline; Utilize pH meter (CHNO60 (828), ORION company (U.S.)) to measure the changing conditions of pH.The OD of engineering bacteria and wild bacterium
600Variation see Fig. 6, the pH of the nutrient solution of engineering bacteria and wild bacterium changes and sees Fig. 7, the hydrogen generation situation of engineering bacteria and wild bacterium is seen Fig. 8, the CO of engineering bacteria and wild bacterium
2Generate situation map 9.
The maximum hydrogen-producing speed of maximum specific growth rate of engineering bacteria and wild bacterium and thalline relatively sees Table 1.
Table 1 maximum growth rate and hydrogen-producing speed (n=3)
Above result shows that after cultivating through batch formula of 12h, the cell density of wild bacterium reaches the highest (OD
600Be 2.26), and interim at the fastest logarithmic growth of product hydrogen, the cell density of two strain engineering bacterias is all than wild bacterium height.Hydrogen is and cell growth link coupled primary metabolite that 2 strain engineering bacterias also show higher hydrogen-producing speed when logarithmic phase, and final hydrogen output is also higher, reaches 76.8mM and 83.0mM respectively.The pH variation tendency of 3 strain bacterium is consistent, all produces acid during the fermentation and makes fermented liquid be acid, and pH drops between the 4.7-4.9 from initial value 6.9.Faster than wild bacterium, this is relevant with them in the high value-added speed of logarithmic phase in the pH of logarithmic phase fall off rate outline for engineering bacteria E.aerogenes IAM1183-O and E.aerogenes IAM1183-AO.The carbonic acid gas output of engineering bacteria E.aerogenes IAM1183-AO will be starkly lower than other two strains bacterium.Compare with the maximum specific growth rate of 2 strain engineering bacterias and maximum hydrogen-producing speed and with wild bacterium, the maximum specific growth rate of wild bacterium is higher than 2 strain engineering bacterias, reaches 0.523h
-1, and the maximum specific growth rate of engineering bacteria E.aerogenes IAM1183-AO is minimum, is 0.523h
-1Maximum hydrogen-producing speed reflection be the high yield output of hydrogen of unit cell unit time, compare with wild bacterium, the maximum hydrogen-producing speed of the thalline of 2 strain engineering bacterias all is improved to some extent, and is respectively 1.18 and 1.45 times of wild-type.
The metabolic flux analysis of embodiment 5, engineering bacteria
Detect the distribution of each metabolic flux in wild bacterium and the engineering bacteria cell respectively, concrete steps are as follows:
(1) seed culture: adopt the 15ml centrifuge tube, LB substratum liquid amount 5ml is from solid plate inoculation bacterium, 37 ℃ of culture temperature, airbath shaking speed 170rpm, incubated overnight.
(2) anaerobism shake-flask culture: adopt 70ml serum bottle anaerobism culturing bottle, dextrose culture-medium liquid amount 20ml (using the air in nitrogen replacement culturing bottle top and the substratum in advance); Plant the inoculum size 2.5% (v/v) of daughter bacteria, 37 ℃ of culture temperature, airbath shaking speed 170rpm.Cultivated 16 hours.
(3) behind the anaerobism shake-flask culture 16h meta-bolites is detected.Behind fermented product centrifuging and taking supernatant, filter.Utilize the output and the composition of high-pressure liquid chromatography metabolite.High-pressure liquid phase gas spectrum is (HPLC-10A, SHIMADZU company (Japan).Concrete detection method is as follows: the 10ml sample is at 12000rpm, 4 ℃ centrifugal 5 minutes, get supernatant frozen in-80 ℃ of refrigerators until measurement.Adopt high performance liquid chromatography (HPLC) to measure glucose, lactic acid, succsinic acid, formic acid, acetate, 2,3-butyleneglycol and concentration of ethanol.
Analytical procedure and condition: chromatographic column is selected Tianjin, island Shim-pack SCR-102H for use, and matrix is PS/DVB, and functional group is-SO
3H.This column dimension is: 300mm (length) * 8mm (internal diameter), particle diameter are 7 μ m.Chromatographiccondition is as follows: 40 ℃ of column temperatures, moving phase 5mM perchloric acid, flow velocity 1.0mlmin
-1Differential detector (RID); Sample feeding amount 20 μ l.The HPLC computer control software CLASS-VP workstation that adopts Tianjin, island company to provide carries out the analyzing and processing of data.
The experiment triplicate, experimental result is as shown in table 2.Data in the table 2 are mean+SD.
Table 2 metabolic flux analysis (n=3)
The result shows, the hydrogen of 2 strain engineering bacterias reaches 1.27 and 1.36mol-hydrogen mol-glucose respectively to the yield of glucose
-1, all be higher than analog value (the 1.16mol-hydrogen mol-glucose of wild bacterium
-1).This explanation can both increase the flux of product hydrogen pathways metabolism effectively to the deactivation of Δ hycA with to the deactivation of Δ hybO, produces the hydrogen yield thereby improve cell.Meanwhile, the said gene modification also has certain influence to the distribution of other meta-bolites.2,3-butyleneglycol, lactic acid, succsinic acid and ethanol all are to rely on NADH in the born of the same parents and the meta-bolites that produces, compare with wild bacterium, and the yield of these materials all increases in 2 strain engineering bacterias to some extent, demonstrate the increase of available reducing power in the born of the same parents, and this is an essential condition that helps producing hydrogen.The acetate of 2 strain engineering bacterias and ethanol production sum all have the raising of certain amplitude than wild type strain, show that formic acid produces the hydrogen approach and is reinforced in producing the hydrogen process, and this has also reached hydrogenlyase negative regulator gene deactivation expected effect.
Test shows, the deactivation meeting of target gene is caused the variation of corresponding enzymic activity in the born of the same parents, and then changes metabolic flux, increases the output of target product.The engineering strain that the present invention obtained has higher hydrogen production potential, can be applicable to ferment for hydrogen production.
Sequence table
<110〉Tsing-Hua University
<120〉hydrogen-producing engineering bacteria and application thereof
<130>CGGNARY81442
<160>10
<210>1
<211>263
<212>PRT
<213〉enteroaerogen (E.aerogenes)
<400>1
Val?Ile?Trp?Ile?Gly?Ala?Gln?Glu?Cys?Thr?Gly?Cys?Thr?Glu?Ser?Leu
1 5 10 15
Leu?Arg?Ala?Thr?His?Pro?Thr?Val?Glu?Asn?Leu?Val?Leu?Glu?Thr?Ile
20 25 30
Ser?Leu?Glu?Tyr?His?Glu?Val?Leu?Ser?Ala?Ala?Phe?Gly?His?Gln?Val
35 40 45
Glu?Glu?Asn?Lys?His?Asn?Ala?Leu?Glu?Lys?Tyr?Lys?Gly?Gln?Tyr?Val
50 55 60
Leu?Val?Val?Asp?Gly?Ser?Ile?Pro?Leu?Lys?Asp?Asn?Gly?Ile?Tyr?Cys
65 70 75 80
Met?Val?Ala?Gly?Glu?Pro?Ile?Val?Asp?His?Ile?Arg?Lys?Ala?Ala?Glu
85 90 95
Gly?Ala?Ala?Ala?Ile?Ile?Ala?Ile?Gly?Ser?Cys?Ser?Ala?Trp?Gly?Gly
100 105 110
Val?Ala?Ala?Ala?Gly?Val?Asn?Pro?Thr?Gly?Ala?Val?Ser?Leu?Gln?Glu
115 120 125
Val?Leu?Pro?Gly?Lys?Thr?Val?Ile?Asn?Ile?Pro?Gly?Cys?Pro?Pro?Asn
130 135 140
Pro?His?Asn?Phe?Leu?Ala?Thr?Val?Ala?His?Ile?Ile?Thr?Tyr?Gly?Lys
145 150 155 160
Pro?Pro?Lys?Leu?Asp?Asp?Lys?Asn?Arg?Pro?Thr?Phe?Ala?Tyr?Gly?Arg
165 170 175
Leu?Ile?His?Glu?His?Cys?Glu?Arg?Arg?Pro?His?Phe?Asp?Ala?Gly?Arg
180 185 190
Phe?Ala?Lys?Glu?Phe?Gly?Asp?Glu?Gly?His?Arg?Glu?Gly?Trp?Cys?Leu
195 200 205
Tyr?His?Leu?Gly?Cys?Lys?Gly?Pro?Glu?Thr?Tyr?Gly?Asn?Cys?Ser?Thr
210 215 220
Leu?Gln?Phe?Cys?Asp?Val?Gly?Gly?Val?Trp?Pro?Val?Ala?Ile?Gly?His
225 230 235 240
Pro?Cys?Tyr?Gly?Cys?Asn?Glu?Glu?Gly?Ile?Gly?Phe?His?Lys?Gly?Ile
245 250 255
His?Gln?Leu?Ala?Asn?Val?Glu
260
<210>2
<211>789
<212>DNA
<213〉enteroaerogen (E.aerogenes)
<400>2
gttatctgga?ttggcgcgca?ggagtgcacc?ggttgtacgg?aatctctgct?tcgtgcaacg 60
catccaacgg?tagaaaacct?cgtactggag?actatctctc?tggagtatca?cgaagtgctt 120
tccgccgcct?tcggtcatca?ggtcgaagag?aacaaacata?acgctcttga?gaagtacaaa 180
gggcagtatg?tgttagtggt?ggatggttcc?atcccattaa?aagataacgg?tatttattgc 240
atggttgccg?gtgagccgat?tgtggatcac?atccgcaaag?cggcggaagg?cgcagcagcc 300
attatcgcta?tcggttcctg?ctctgcgtgg?ggcggtgttg?ccgcagctgg?agttaaccca 360
actggcgcag?tcagcctgca?agaagttctg?ccaggcaaaa?ccgttatcaa?tattccgggc 420
tgcccgccga?acccgcacaa?cttcctcgcg?accgttgcgc?acatcatcac?ttacggcaaa 480
ccgccgaaac?tggatgacaa?aaaccgtccg?accttcgcct?atggccgtct?gattcacgaa 540
cactgcgaac?gtcgcccgca?cttcgatgct?ggtcgttttg?ccaaagagtt?cggtgatgaa 600
ggccaccgcg?aaggctggtg?cctgtaccac?ctcggctgta?aagggccaga?aacttacggc 660
aactgctcaa?cgctgcaatt?ctgcgatgtt?ggcggtgtgt?ggccggtggc?gattggtcac 720
ccttgctatg?gctgtaacga?agaaggtatc?ggcttccata?aaggcatcca?tcaactggcc 780
aacgtcgaa 789
<210>3
<211>1910
<212>DNA
<213〉artificial sequence
<400>3
aatctctgct?tcgtgcaacg?catccaacgg?tagaaaacct?tttggtgact?gcgctcctcc 60
aagccagtta?cctcggttca?aagagttggt?agctcagaga?accttcgaaa?aaccgccctg 120
caaggcggtt?ttttcgtttt?cagagcaaga?gattacgcgc?agaccaaaac?gatctcaaga 180
agatcatctt?attaatcaga?taaaatattt?ctagatttca?gtgcaattta?tctcttcaaa 240
tgtagcacct?gaagtcagcc?ccatacgata?taagttgtaa?ttctcatgtt?tgacagctta 300
tcatcgataa?gctttaatgc?ggtagtttat?cacagttaaa?ttgctaacgc?agtcaggcac 360
cgtgtatgaa?atctaacaat?gcgctcatcg?tcatcctcgg?caccgtcacc?ctggatgctg 420
taggcatagg?cttggttatg?ccggtactgc?cgggcctctt?gcgggatatc?gtccattccg 480
acagcatcgc?cagtcactat?ggcgtgctgc?tagcgctata?tgcgttgatg?caatttctat 540
gcgcacccgt?tctcggagca?ctgtccgacc?gctttggccg?ccgcccagtc?ctgctcgctt 600
cgctacttgg?agccactatc?gactacgcga?tcatggcgac?cacacccgtc?ctgtggatcc 660
tctacgccgg?acgcatcgtg?gccggcatca?ccggcgccac?aggtgcggtt?gctggcgcct 720
atatcgccga?catcaccgat?ggggaagatc?gggctcgcca?cttcgggctc?atgagcgctt 780
gtttcggcgt?gggtatggtg?gcaggccccg?tggccggggg?actgttgggc?gccatctcct 840
tgcatgcacc?attccttgcg?gcggcggtgc?tcaacggcct?caacctacta?ctgggctgct 900
tcctaatgca?ggagtcgcat?aagggagagc?gtcgaccgat?gcccttgaga?gccttcaacc 960
cagtcagctc?cttccggtgg?gcgcggggca?tgactatcgt?cgccgcactt?atgactgtct 1020
tctttatcat?gcaactcgta?ggacaggtgc?cggcagcgct?ctgggtcatt?ttcggcgagg 1080
accgctttcg?ctggagcgcg?acgatgatcg?gcctgtcgct?tgcggtattc?ggaatcttgc 1140
acgccctcgc?tcaagccttc?gtcactggtc?ccgccaccaa?acgtttcggc?gagaagcagg 1200
ccattatcgc?cggcatggcg?gccgacgcgc?tgggctacgt?cttgctggcg?ttcgcgacgc 1260
gaggctggat?ggccttcccc?attatgattc?ttctcgcttc?cggcggcatc?gggatgcccg 1320
cgttgcaggc?catgctgtcc?aggcaggtag?atgacgacca?tcagggacag?cttcaaggat 1380
cgctcgcggc?tcttaccagc?ctaacttcga?tcactggacc?gctgatcgtc?acggcgattt 1440
atgccgcctc?ggcgagcaca?tggaacgggt?tggcatggat?tgtaggcgcc?gccctatacc 1500
ttgtctgcct?ccccgcgttg?cgtcgcggtg?catggagccg?ggccacctcg?acctgaatgg 1560
aagccggcgg?cacctcgcta?acggattcac?cactccaaga?attggagcca?atcaattctt 1620
gcggagaact?gtgaatgcgc?aaaccaaccc?ttggcagaac?atatccatcg?cgtccgccat 1680
ctccagcagc?cgcacgcggc?gcatctcggg?cagcgttggg?tcctggccac?gggtgcgcat 1740
gatcgtgctc?ctgtcgttga?ggacccggct?aggctggcgg?ggttgcctta?ctggttagca 1800
gaatgaatca?ccgatacgcg?agcgaacgtg?aagcgactgc?tgctgcaaaa?cgtctgcgac 1860
ctgagcaaca?gattggtcac?ccttgctatg?gctgtaacga?agaaggtatc 1910
<210>4
<211>134
<212>PRT
<213〉enteroaerogen (E.aerogenes)
<400>4
Arg?His?Arg?Arg?Tyr?Gln?Asp?Gln?Trp?Arg?Gln?Tyr?Cys?Asn?Ser?Leu
1 5 10 15
Val?Gln?Gly?Ile?Thr?Leu?Ser?Lys?Ala?Arg?Leu?His?His?Ala?Met?Ser
20 25 30
Cys?Ala?Pro?Asp?Lys?Glu?Leu?Cys?Phe?Val?Leu?Phe?Glu?His?Phe?Gln
35 40 45
Val?Tyr?Val?Ala?Leu?Ala?Glu?Gly?Phe?Asn?Asn?His?Thr?Ile?Glu?Tyr
50 55 60
Tyr?Val?Glu?Thr?Arg?Asn?Gly?Asp?Asp?Lys?Arg?Leu?Ile?Ala?Gln?Ala
65 70 75 80
Thr?Leu?Ala?Ser?Asp?Gly?Thr?Val?Asp?Gly?Arg?Ile?Ser?Asn?Arg?Ser
85 90 95
Arg?Glu?Gln?Val?Leu?Glu?His?Tyr?Leu?Ala?Ile?Ile?Ala?Ser?Val?Tyr
100 105 110
Asp?Arg?Leu?Tyr?Asp?Ala?Met?Glu?His?Asp?Gln?Pro?Val?Asp?Leu?Ser
115 120 125
His?Leu?Ala?Leu?Ala?His
130
<210>5
<211>405
<212>DNA
<213〉enteroaerogen (E.aerogenes)
<400>5
cgtcaccgcc?gctatcagga?tcagtggcgc?cagtactgca?attcgctggt?tcagggcatc 60
accctgtcaa?aagcgcgttt?gcatcatgcg?atgagctgcg?cgccggacaa?agagctgtgc 120
ttcgtcctgt?ttgaacattt?tcaggtgtat?gtcgcgctgg?cggaagggtt?caacaaccac 180
accatcgagt?actacgtcga?aacgcgcaat?ggtgatgata?agcgattgat?tgctcaggca 240
acgctggcat?ccgacggtac?cgttgacggc?cggatcagca?accgttcgcg?cgaacaggtg 300
ctggaacatt?acctggccat?tattgccagc?gtctatgacc?gtctgtatga?cgccatggaa 360
cacgaccagc?cggtggattt?aagccatctg?gcgctggccc?attaa 405
<210>6
<211>1693
<212>DNA
<213>6
<400〉artificial sequence
ctgcaattcg?ctggttcagg?gcatcaccct?gtcaaaagcg?ataggctccg?cccccctgac 60
gagcatcaca?aaaatcgacg?ctcaagtcag?aggtggcgaa?acccgacagg?actataaaga 120
taccaggcgt?ttccccctgg?aagctccctc?gtgcgctctc?ctgttccgac?cctgccgctt 180
accggatacc?tgtccgcctt?tctcccttcg?ggaagcgtgg?cgctttctca?tagctcacgc 240
tgtaggtatc?tcagttcggt?gtaggtcgtt?cgctccaagc?tgggctgtgt?gcacgaaccc 300
cccgttcagc?ccgaccgctg?cgccttatcc?ggtaactatc?gtcttgagtc?caacccggta 360
agacacgact?tatcgccact?ggcagcagcc?actggtaaca?ggattagcag?agcgaggtat 420
gtaggcggtg?ctacagagtt?cttgaagtgg?tggcctaact?acggctacac?tagaaggaca 480
gtatttggta?tctgcgctct?gctgaagcca?gttaccttcg?gaaaaagagt?tggtagctct 540
tgatccggca?aacaaaccac?cgctggtagc?ggtggttttt?ttgtttgcaa?gcagcagatt 600
acgcgcagaa?aaaaaggatc?tcaagaagat?cctttgatct?tttctacggg?gtctgacgct 660
cagtggaacg?aaaactcacg?ttaagggatt?ttggtcatga?acaataaaac?tgtctgctta 720
cataaacagt?aatacaaggg?gtgttatgag?ccatattcaa?cgggaaacgt?cttgctctag 780
gccgcgatta?aattccaaca?tggatgctga?tttatatggg?tataaatggg?ctcgcgataa 840
tgtcgggcaa?tcaggtgcga?caatctatcg?attgtatggg?aagcccgatg?cgccagagtt 900
gtttctgaaa?catggcaaag?gtagcgttgc?caatgatgtt?acagatgaga?tggtcagact 960
aaactggctg?acggaattta?tgcctcttcc?gaccatcaag?cattttatcc?gtactcctga 1020
tgatgcatgg?ttactcacca?ctgcgatccc?cgggaaaaca?gcattccagg?tattagaaga 1080
atatcctgat?tcaggtgaaa?atattgttga?tgcgctggca?gtgttcctgc?gccggttgca 1140
ttcgattcct?gtttgtaatt?gtccttttaa?cagcgatcgc?gtatttcgtc?tcgctcaggc 1200
gcaatcacga?atgaataacg?gtttggttga?tgcgagtgat?tttgatgacg?agcgtaatgg 1260
ctggcctgtt?gaacaagtct?ggaaagaaat?gcataaactt?ttgccattct?caccggattc 1320
agtcgtcact?catggtgatt?tctcacttga?taaccttatt?tttgacgagg?ggaaattaat 1380
aggttgtatt?gatgttggac?gagtcggaat?cgcagaccga?taccaggatc?ttgccatcct 1440
atggaactgc?ctcggtgagt?tttctccttc?attacagaaa?cggctttttc?aaaaatatgg 1500
tattgataat?cctgatatga?ataaattgca?gtttcatttg?atgctcgatg?agtttttcta 1560
agaattaatt?catgagcgga?tacatatttg?aatgtattta?gaaaaataaa?caaatagggg 1620
ttccgcgcac?atttccccga?aaagtgccac?ctgtatgacg?ccatggaaca?cgaccagccg 1680
gtggatttaa?gcc 1693
<210>7
<211>40
<212>DNA
<213〉artificial sequence
<400>7
aatctctgct?tcgtgcaacg?catccaacgg?tagaaaacct 40
<210>8
<211>40
<212>DNA
<213〉artificial sequence
<400>8
gataccttct?tcgttacagc?catagcaagg?gtgaccaatc 40
<210>9
<211>40
<212>DNA
<213〉artificial sequence
<400>9
ctgcaattcg?ctggttcagg?gcatcaccct?gtcaaaagcg 40
<210>10
<211>40
<212>DNA
<213〉artificial sequence
<400>10
ggcttaaatc?caccggctgg?tcgtgttcca?tggcgtcata 40
Claims (8)
1. hydrogen-producing engineering bacteria, be following a) or b) engineering bacteria:
A) engineering bacteria that obtains of the Δ hybO albumen among the deactivation E.aerogenes IAM1183;
The proteic aminoacid sequence of described Δ hybO is the sequence 1 in the sequence table; The nucleotide sequence of the proteic encoding gene of described Δ hybO is the sequence 2 in the sequence table;
Δ hybO albumen among the described deactivation E.aerogenes IAM1183 is realized by dna fragmentation Q is imported among the described E.aerogenes IAM1183;
Described dna fragmentation Q is followed successively by homology arm T to the downstream from the upstream
1, dna fragmentation N, homology arm T
2Described homology arm T
1With homology arm T
2Can with the proteic encoding gene generation of described Δ hybO homologous recombination, the described Δ hybO of deactivation albumen; Described dna fragmentation N is the antibiotics resistance fragment;
Described homology arm T
1Nucleotide sequence be sequence 7 in the sequence table; Described homology arm T
2Nucleotide sequence be sequence 8 in the sequence table; Described dna fragmentation N is the tetracyclin resistance fragment;
B) engineering bacteria that obtains of Δ hybO albumen among the deactivation E.aerogenes IAM1183 and Δ hycA albumen;
The proteic aminoacid sequence of described Δ hycA is the sequence 4 in the sequence table; The nucleotide sequence of the proteic encoding gene of described Δ hycA is the sequence 5 in the sequence table;
Δ hybO albumen among the described deactivation E.aerogenes IAM1183 and Δ hycA albumen are realized by dna fragmentation Q and dna fragmentation P are imported among the described E.aerogenes IAM1183;
Described dna fragmentation P is followed successively by homology arm T to the downstream from the upstream
3, dna fragmentation M, homology arm T
4Described homology arm T
3With homology arm T
4Can with the proteic encoding gene generation of described Δ hycA homologous recombination, the described Δ hycA of deactivation albumen; Described dna fragmentation M is the antibiotics resistance fragment;
Described homology arm T
3Nucleotide sequence be sequence 9 in the sequence table; Described homology arm T
4Nucleotide sequence be sequence 10 in the sequence table; Described dna fragmentation M is the kalamycin resistance fragment.
2. engineering bacteria as claimed in claim 1 is characterized in that: the nucleotides sequence of described dna fragmentation Q is classified the sequence 3 in the sequence table as.
3.DNA fragment Q is followed successively by homology arm T to the downstream from the upstream
1, dna fragmentation N, homology arm T
2Described homology arm T
1With homology arm T
2Can with the proteic encoding gene generation of the Δ hybO homologous recombination of E.aerogenes IAM1183, deactivation Δ hybO albumen; The proteic aminoacid sequence of described Δ hybO is the sequence 1 in the sequence table; The nucleotide sequence of the proteic encoding gene of described Δ hybO is the sequence 2 in the sequence table;
Described homology arm T
1Nucleotide sequence be sequence 7 in the sequence table; Described homology arm T
2Nucleotide sequence be sequence 8 in the sequence table; Described dna fragmentation N is the tetracyclin resistance fragment.
4. dna fragmentation Q as claimed in claim 3 is characterized in that: the nucleotides sequence of described dna fragmentation N is classified the sequence 3 in the sequence table as.
5. the expression cassette that contains claim 3 or 4 described dna fragmentation Q.
6. the recombinant expression vector that contains claim 3 or 4 described dna fragmentation Q.
7. the transgenic cell line that contains claim 3 or 4 described dna fragmentation Q.
8. the reorganization bacterium that contains claim 3 or 4 described dna fragmentation Q.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101152311A CN101608170B (en) | 2008-06-19 | 2008-06-19 | Hydrogen-producing engineering bacteria and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101152311A CN101608170B (en) | 2008-06-19 | 2008-06-19 | Hydrogen-producing engineering bacteria and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101608170A CN101608170A (en) | 2009-12-23 |
CN101608170B true CN101608170B (en) | 2011-06-29 |
Family
ID=41482080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101152311A Expired - Fee Related CN101608170B (en) | 2008-06-19 | 2008-06-19 | Hydrogen-producing engineering bacteria and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101608170B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2880819A1 (en) * | 2012-08-02 | 2014-02-06 | University Of Central Florida Research Foundation, Inc. | Compositions and methods for genetic constructs |
-
2008
- 2008-06-19 CN CN2008101152311A patent/CN101608170B/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
赵洪新等.产气肠杆菌(E.aerogenes IAMl138)甲酸氢酶基因的克隆及高效产氢工程菌的构建.《2007年中国微生物学会学术年会》.2007,173-174. * |
Also Published As
Publication number | Publication date |
---|---|
CN101608170A (en) | 2009-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wen et al. | Improved n-butanol production from Clostridium cellulovorans by integrated metabolic and evolutionary engineering | |
CN106687576B (en) | Altered host cell pathways for enhanced ethanol production | |
CN107142253B (en) | Xylanase mutant and preparation method and application thereof | |
AU2002353763B2 (en) | Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor | |
Raj et al. | Cloning and characterization of the Zymobacter palmae pyruvate decarboxylase gene (pdc) and comparison to bacterial homologues | |
CN112501102B (en) | Escherichia coli recombinant bacterium for efficiently producing tetrahydropyrimidine | |
CN110846363B (en) | Method for producing rebaudioside D by one-pot method | |
Gurgu et al. | Fermentation of cellobiose to ethanol by industrial Saccharomyces strains carrying the β-glucosidase gene (BGL1) from Saccharomycopsis fibuligera | |
AU2002353763A1 (en) | Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor | |
CA2886137A1 (en) | Recombinant cell, and method for producing isoprene | |
CN110564710B (en) | Xylanase mutant with high catalytic efficiency and construction method and application thereof | |
JP2012510263A5 (en) | ||
CN112921047A (en) | Shewanella electrogenesis strain for over-expressing cytochrome protein and construction method and application thereof | |
Zhou et al. | A novel low-temperature-active exo-inulinase identified based on molecular-activity strategy from Sphingobacterium sp. GN25 isolated from feces of Grus nigricollis | |
Liu et al. | Metal-organic frameworks coupling simultaneous saccharication and fermentation for enhanced butyric acid production from rice straw under visible light by Clostridium tyrobutyricum CtΔack:: cat1 | |
CN104789586B (en) | Genome of E.coli integration vector, genetic engineering bacterium and the application in xylitol is produced | |
CN101608170B (en) | Hydrogen-producing engineering bacteria and application thereof | |
CN103266127B (en) | Method for converting bacillus subtilis by electric shock | |
CN101608171A (en) | One hydrogen-producing engineering bacteria and application thereof | |
CN113046286B (en) | Shewanella strain for promoting biofilm formation and construction method and application thereof | |
CN101633690B (en) | Hydrogen production associated protein, coding genes thereof and application thereof | |
CN113272438A (en) | Recombinant yeast and method for producing ethanol using same | |
CN114606146B (en) | Yeast for producing D-limonene and application thereof | |
CN103571858B (en) | Chinese herbaceous peony Mang ox geranyl pyrophosphate synthase (PLGGPS) gene and coded product thereof and application | |
Tamaru et al. | Lignocellulosic biomass utilization toward biorefinery using meshophilic Clostridial species |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 Termination date: 20120619 |